Form 8-K - Current report:
SEC Accession No. 0001213900-25-021345
Filing Date
2025-03-07
Accepted
2025-03-07 07:00:12
Documents
13
Period of Report
2025-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0233504-8k_silopharma.htm   iXBRL 8-K 24641
  Complete submission text file 0001213900-25-021345.txt   195765

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE silo-20250304.xsd EX-101.SCH 3021
3 XBRL LABEL FILE silo-20250304_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE silo-20250304_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0233504-8k_silopharma_htm.xml XML 3566
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Filer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41512 | Film No.: 25717534
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)